Blend Labs price target lowered to $5 from $7 at Citizens
Citizens analyst Aaron Kimson lowered the firm’s price target on Blend Labs (BLND) to $5 from $7 and keeps an Outperform rating on the shares. The company reported “strong” Q4 results but its Q1 guidance is “disappointing,” the analyst tells investors in a research note. Citizens reduced estimates but says the financial institution customers Blend serves will want to stay in the mortgage business.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Read More on BLND:
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
3 Altcoins to Watch in the First Week of November 2026
Trump and Jim Cramer Defend SpaceX as Musk Wants to Enter the Telecom Market
Gold’s lost haven allure to swing back into view on deficit woes
Crypto prices
More
